Marrone Bio Investors Say Ernst & Young Must Face Claims

By Kali Hays · August 2, 2016, 4:38 PM EDT

A class of Marrone Bio Innovations Inc. shareholders on Monday urged a California federal court not to dismiss claims against Ernst & Young LLP over its alleged role in the bio-based...

To view the full article, register now.